Interactive Blog

One engine, promising drugs for many diseases

March 15, 2022

10 minute read

We used our engine to test tens of thousands of drugs for their ability to induce therapeutic immune cell behaviors and validated them in follow-up experiments – surfacing promising therapies for multiple age-related diseases. This approach can be used by our partners in a broad range of therapeutic areas.

Dive into these results in an interactive blog post

At Spring, we've dedicated ourselves to building a technology engine that helps those searching for therapies for many different diseases. This engine is capable of generating strong conviction in screening hits using complex, data-rich assays across thousands of drugs in a broad range of therapeutic areas.

One such therapeutic area that we've extensively validated is immune aging-related diseases. Explore our interactive blog post to learn more.

AUTHORS
Charlie Marsh, Ben Komalo, Brandon White, Ben Kamens, 

Matt Booty, Christian Elabd

THANK YOU

Spring’s AI R&D platform has been acquired by a major biotech leader in the Bay Area.

Read more →


Thank you to our trusted partners across biotech, pharma, and academic research.

Our scientific resources are still available here →

© 2025 Spring Discovery.

All rights reserved.

THANK YOU

Spring’s AI R&D platform has been acquired by a major biotech leader in the Bay Area.

Read more →


Thank you to our trusted partners across biotech, pharma, and academic research.

Our scientific resources are still available here →

© 2025 Spring Discovery.

All rights reserved.

THANK YOU

Spring’s AI R&D platform has been acquired by a major biotech leader in the Bay Area.

Read more →


Thank you to our trusted partners across biotech, pharma, and academic research.

Our scientific resources are still available here →

© 2025 Spring Discovery.

All rights reserved.